These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23295208)

  • 1. High-dose cyclophosphamide therapy associated with diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Respiration; 2013; 86(6):453-61. PubMed ID: 23295208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
    Majhail NS; Parks K; Defor TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokine profiles at the onset of severe, diffuse alveolar hemorrhage complicating allogeneic hematopoietic stem cell transplantation, treated successfully with pulse intravenous cyclophosphamide.
    Koh H; Nakamae H; Koh KR; Ohsawa M; Nakane T; Takeoka Y; Aimoto R; Aimoto M; Wada-Inoue E; Terada Y; Yamane T; Hino M
    Acta Haematol; 2010; 124(3):171-5. PubMed ID: 20938173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure after allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Zhao T; Yan CH; Sun YQ; Liu KY; Huang XJ
    Int J Cardiol; 2013 Sep; 167(6):2502-6. PubMed ID: 22727962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid.
    Wanko SO; Broadwater G; Folz RJ; Chao NJ
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):949-53. PubMed ID: 16920561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
    Hicks K; Peng D; Gajewski JL
    Bone Marrow Transplant; 2002 Dec; 30(12):975-8. PubMed ID: 12476294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
    Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
    Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
    Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review.
    Loecher AM; West K; Quinn TD; Defayette AA
    Pharmacotherapy; 2021 Nov; 41(11):943-952. PubMed ID: 34618944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage.
    Cartin-Ceba R; Peikert T; Ashrani A; Keogh K; Wylam ME; Ytterberg S; Specks U
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):301-10. PubMed ID: 23983016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.
    Liu QF; Fan ZP; Wu MQ; Sun J; Wu XL; Xu D; Jiang QL; Zhang Y; Huang F; Wei YQ; Zhao J; Yu GP; Meng FY
    Ann Hematol; 2013 May; 92(5):679-87. PubMed ID: 23274355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation.
    Wu J; Fu HX; He Y; Mo XD; Liu X; Cai X; Gui RY; Liu HX; Yan CH; Chen YH; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Bone Marrow Transplant; 2021 Sep; 56(9):2097-2107. PubMed ID: 33846561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.